Maternal Newborn Health Registry

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
NICHD Global Network for Women's and Children's Health
Study ID
NCT01073475
Status
Recruiting

Conditions

  • Pregnancy Outcome Trends in Low-resource Geographic Areas

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • There is no intervention associated with the parent MNHR study. For the MNHR COVID sub-study, participants will be asked to provide a blood specimen at or near delivery. — OTHER
    There is no intervention associated with the parent MNHR study For the MNHR COVID sub-study, each woman will be asked to provide a blood specimen of approximately 3-5 cc at or near delivery (at delivery or 14 days after) to be tested for COVID-19 antibodies. The person collecting the specimen will be a trained member of the registry staff. The ZEUS ELISA SARS-CoV-2 IgG Test System will be used and run at each site. RTI International will provide central quality support of the analyses.

Study Details

The primary purpose of this population-based study is to quantify and understand the trends in pregnancy outcomes in defined low-resource geographic areas over time, in order to provide population-based data on stillbirths, neonatal and maternal mortality.

Key Dates

Start date
May 31, 2008
Status verified
Jan 2026
Primary completion
Jan 31, 2030
Completion
May 31, 2030

Study Design

Enrollment
950,000 participants (estimated)

Arms

  • Arm: Pregnant women
    Pregnant women in the MNH cluster
  • Arm: Male and Female Infants
    Male and Female Infants delivered in the clusters

Primary Outcome Measure

Maternal mortality rate [ Time Frame: 42 days post delivery ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233
Waldemar A. Carlo, MD
205-934-4680
Waldemar A. Carlo, MD (PRINCIPAL_INVESTIGATOR)
University of Colorado DenverAuroraColorado80045
Nancy Krebs, MD
Nancy Krebs, MD (SUB_INVESTIGATOR)
Indiana University School of MedicineIndianapolisIndiana46202-5119
Ed Liechty, MD
317-274-4715
Ed Liechty, MD (PRINCIPAL_INVESTIGATOR)
Boston UniversityBostonMassachusetts02115
Patricia L. Hibberd, MD, PhD
617-636-2431
Patricia L. Hibberd, MD, PhD (PRINCIPAL_INVESTIGATOR)
Columbia UniversityNew YorkNew York10032
Robert Goldenberg, MD
215-762-2014
Robert Goldenberg, MD (PRINCIPAL_INVESTIGATOR)
University of North CarolinaChapel HillNorth Carolina27510
Carl Bose, MD
984-974-7849
Carl Bose, MD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson UniversityPhiladelphiaPennsylvania19107
Richard J. Derman, MD, MPH
302-733-3350
Richard J. Derman, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of VirginaCharlottesvilleVirginia22908
Principal Investigator
434-924-5621
William A. Petri, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL